Current trends in targeted therapies for glioblastoma multiforme

F Ohka, A Natsume… - Neurology research …, 2012 - Wiley Online Library
Glioblastoma multiforme (GBM) is one of the most frequently occurring tumors in the central
nervous system and the most malignant tumor among gliomas. Despite aggressive …

Stromal dynamic reciprocity in cancer: intricacies of fibroblastic-ECM interactions

J Alexander, E Cukierman - Current opinion in cell biology, 2016 - Elsevier
Highlights•Innate mesenchymal-stroma maintains a tumor-suppressive homeostatic
equilibrium.•Fibroblastic-ECM interplay is referred to as stromal dynamic reciprocity.• …

Tumor evasion from T cell surveillance

K Töpfer, S Kempe, N Müller, M Schmitz… - BioMed Research …, 2011 - Wiley Online Library
An intact immune system is essential to prevent the development and progression of
neoplastic cells in a process termed immune surveillance. During this process the innate …

Convection-enhanced delivery for the treatment of glioblastoma

MA Vogelbaum, MK Aghi - Neuro-oncology, 2015 - academic.oup.com
Effective treatment of glioblastoma (GBM) remains a formidable challenge. Survival rates
remain poor despite decades of clinical trials of conventional and novel, biologically …

[HTML][HTML] Convection-enhanced delivery: connection to and impact of interstitial fluid flow

CA Stine, JM Munson - Frontiers in oncology, 2019 - frontiersin.org
Convection-enhanced delivery (CED) is a method used to increase transport of therapeutics
in and around brain tumors. CED works through locally applying a pressure differential to …

Targeting tumor cell motility to prevent metastasis

TD Palmer, WJ Ashby, JD Lewis, A Zijlstra - Advanced drug delivery …, 2011 - Elsevier
Mortality and morbidity in patients with solid tumors invariably result from the disruption of
normal biological function caused by disseminating tumor cells. Tumor cell migration is …

Lessons from anti–vascular endothelial growth factor and anti–vascular endothelial growth factor receptor trials in patients with glioblastoma

C Lu-Emerson, DG Duda, KE Emblem… - Journal of Clinical …, 2015 - ascopubs.org
Treatment of glioblastoma (GBM), the most common primary malignant brain tumor in adults,
remains a significant unmet need in oncology. Historically, cytotoxic treatments provided …

[HTML][HTML] TGF-β signaling in bone remodeling and osteosarcoma progression

A Lamora, J Talbot, M Mullard… - Journal of clinical …, 2016 - mdpi.com
Osteosarcomas are the most prevalent malignant primary bone tumors in children. Despite
intensive efforts to improve both chemotherapeutics and surgical management, 40% of all …

Tumor stroma as targets for cancer therapy

J Zhang, J Liu - Pharmacology & therapeutics, 2013 - Elsevier
Cancer is not only composed malignant epithelial component but also stromal components
such as fibroblasts, endothelial cells, and inflammatory cells, by which an appropriate tumor …

Therapeutic potential of targeting micro RNA‐10b in established intracranial glioblastoma: first steps toward the clinic

NM Teplyuk, EJ Uhlmann, G Gabriely… - EMBO molecular …, 2016 - embopress.org
Abstract Micro RNA‐10b (miR‐10b) is a unique oncogenic mi RNA that is highly expressed
in all GBM subtypes, while absent in normal neuroglial cells of the brain. miR‐10b inhibition …